A two year BTV-8 vaccination follow up: Molecular diagnostics and assessment of humoral and cellular immune reactions

Veterinary Microbiology

Volumn 154, Issue 3-4, 2012, Pages 247-256

  Hund, Alexandra ^a,b   Gollnick, Nicole ^b   Sauter Louis, Carola ^b   Neubauer Juric, Antonie ^a   Lahm, Harald ^a   Büttner, Mathias ^a  

^a Bavarian Health and Food Safety Authority   (Germany)

^b UNIVERSITY OF MUNICH   (Germany)

Author keywords

Bavaria; Bluetongue vaccination campaign; Immune responses; Molecular diagnostics

Indexed keywords

BLUETONGUE ORBIVIRUS VACCINE; GAMMA INTERFERON; NEUTRALIZING ANTIBODY; UNCLASSIFIED DRUG; VIRUS VACCINE;

ANTIBODY TITER; ARTICLE; BLUETONGUE; BLUETONGUE ORBIVIRUS; CATTLE; CELLULAR IMMUNITY; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; CYTOKINE RELEASE; ENZYME LINKED IMMUNOSORBENT ASSAY; ENZYME LINKED IMMUNOSPOT ASSAY; FOLLOW UP; GERMANY; HUMORAL IMMUNITY; IN VITRO STUDY; MOLECULAR DIAGNOSIS; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SERUM NEUTRALIZATION TEST; SHEEP; VACCINATION; VIRUS GENOME; VIRUS NEUTRALIZATION;

ANIMALS; ANTIBODIES, NEUTRALIZING; ANTIBODIES, VIRAL; BLUETONGUE; BLUETONGUE VIRUS; CATTLE; ENZYME-LINKED IMMUNOSORBENT ASSAY; ENZYME-LINKED IMMUNOSPOT ASSAY; FOLLOW-UP STUDIES; GERMANY; NEUTRALIZATION TESTS; PATHOLOGY, MOLECULAR; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SHEEP; SHEEP, DOMESTIC; VACCINATION; VACCINES, INACTIVATED;

ANIMALIA; BLUETONGUE VIRUS; BOS; OVIS ARIES;

EID: 84855972185     PISSN: 03781135     EISSN: 18732542     Source Type: Journal    
DOI: 10.1016/j.vetmic.2011.07.019     Document Type: Article

References (36)

1. Bartram D.J., Heasman L., Batten C.A., Oura C.A.L., Plana-Durán J., Yuen H.M., Wylie A.D.M. Neutralising antibody responses in cattle and sheep following booster vaccination with two commercial inactivated bluetongue virus serotype 8 vaccines. Vet. J. 2011, 188:193-196.
2. Bexiga R., Guyot H., Saegerman C., Mauroy A., Rollin F., Thiry E., Philbey A.W., Logue D.N., Mellor D.J., Barrett D.C., Ellis K. Clinical differentiation of malignant catarrhal fever, mucosal disease and bluetongue. Vet. Rec. 2007, 161:858-859.
3. BlauzungenImpfStV Verordnung über bestimmte Impfstoffe zum Schutz vor der Blauzungenkrankheit in der Fassung vom 2 Mai 2008. Bundesanzeiger 2008, 1599.
4. Calistri P., Giovannini A., Savini G., Bonfanti L., Cordioli P., Lelli R., Caporale V. Antibody response in cattle vaccinated against bluetongue serotype 8 in Italy. Transboundary Emerg. Dis. 2010, 57:180-184.
5. Commission, European Community, 2008. Commission Decision approving the emergency vaccination plans against bluetongue of certain Member States and fixing the level of the Community's financial contribution for 2007 and 2008. In 2008/655/EC, Commission, E., ed.(Official Journal of the European Union).
6. Conraths F.J., Gethmann J.M., Staubach C., Mettenleiter T.C., Beer M., Hoffmann B. Epidemiology of bluetongue virus serotype 8. Germany. Emerg. Infect. Dis. 2009, 15:433-435.
7. Eschbaumer M., Hoffmann B., König P., Teifke J.P., Gethmann J.M., Conraths F.J., Probst C., Mettenleiter T.C., Beer M. Efficacy of three inactivated vaccines against bluetongue virus serotype 8 in sheep. Vaccine 2009, 27:4169-4175.
8. Gethmann J., Hüttner K., Heyne H., Probst C., Ziller M., Beer M., Hoffmann B., Mettenleiter T.C., Conraths F.J. Comparative safety study of three inactivated BTV-8 vaccines in sheep and cattle under field conditions. Vaccine 2009, 27:4118-4126.
9. Hateley G. Bluetongue in northern Europe: the story so far. In Pract. 2009, 31:202-209.
10. Hoegen B., Saalmüller A., Röttgen M., Rziha H.-J., Geldermann H., Reiner G., Pfaff E., Büttner M. Interferon-gamma response of PBMC indicates productive pseudorabies virus (PRV) infection in swine. Vet. Immunol. Immunopathol. 2004, 102:389-397.
11. Hoffmann B., Depner K., Schirrmeier H., Beer M. A universal heterologous internal control system for duplex real-time RT-PCR assays used in a detection system for pestiviruses. J. Virol. Methods 2006, 136:200-209.
12. Hofmann M.A., Renzullo S., Mader M., Chaignat V., Worwa G., Thuer B. Genetic characterization of toggenburg orbivirus, a new bluetongue virus, from goats, Switzerland. Emerg. Infect. Dis. 2008, 14:1855-1861.
13. Huismans H., Erasmus B.J. Identification of the serotype-specific antigens of bluetongue virus. Onderstepoort J. Vet. Res. 1981, 48:51-58.
14. Jeggo M.H., Wardley J.C. Generation of cross-reactive cytotoxic T lymphocytes following immunization of mice with various bluetongue virus types. Immunology 1982, 45:629-635.
15. Jeggo M.H., Wardley R.C. Production of murine cytotoxic T lymphocytes by bluetongue virus following various immunisation procedures. Res. Vet. Sci. 1982, 33:212-215.
16. Jeggo M.H., Wardley R.C., Brownlie J.A. A study of the role of cell-mediated immunity in bluetongue virus infection in sheep, using cellular adoptive transfer techniques. Immunology 1984, 52:403-410.
17. Kahlon J., Sugiyama K., Roy P. Molecular basis of bluetongue virus neutralization. J. Virol. 1983, 48:627-632.
18. Maan S., Maan N.S., Samuel A.R., O'Hara R., Meyer A.J., Rao S., Mertens P.P. Completion of the sequence analysis and comparisons of genome segment 2 (encoding outer capsid protein VP2) from representative isolates of the 24 bluetongue virus serotypes. Vet. Ital. 2004, 40:484-488.
19. MacLachlan N.J., Drew C.P., Darpel K.E., Worwa G. The pathology and pathogenesis of bluetongue. J. Comp. Pathol. 2009, 141:1-16.
20. Mayr A. Quantitative Bestimmung der Virusinfektiosität (Virustitration). Virologische Arbeitsmethoden 1974, 35-39. VEB Gustav Fischer Verlag, Jena. A. Mayr, P.A. Bachmann, B. Bibrack, G. Wittmann (Eds.).
21. Oura C.A.L., Wood J.L.N., Sanders A.J., Bin-Tarif A., Henstock M., Edwards L., Floyd T., Simmons H., Batten C.A. Seroconversion, neutralising antibodies and protection in bluetongue serotype 8 vaccinated sheep. Vaccine 2009, 27:7326-7330.
22. Roy P., Bishop D.H.L., LeBlois H., Erasmus B.J. Long-lasting protection of sheep against bluetongue challenge after vaccination with virus-like particles: evidence for homologous and partial heterologous protection. Vaccine 1994, 12:805-811.
23. Saegerman C., Hubaux M., Urbain B., Lengele L., Berkvens D. Regulatory issues surrounding the temporary authorisation of animal vaccination in emergency situations: the example of bluetongue in Europe. Rev. Sci. Tech. 2007, 26:395-413.
24. Savini Assessment of efficacy of a bivalent BTV-2 and BTV-4 inactivated vaccine by vaccination and challenge in cattle. Vet. Microbiol. 2009, 133:1-8.
25. Savini G., MacLachlan N.J., Sánchez-Vizcaíno J.M., Zientara S. Vaccines against bluetongue in Europe. Comp. Immunol. Microbiol. Infect. Dis. 2008, 31:101-120.
26. Savini G., Monaco F., Calistri P., Panichi G., Ruiu A., Leone A., Caporale V. Neutralising antibody response in cattle after vaccination with monovalent modified-live vaccine against bluetongue virus serotype 2. Vet. Ital. 2004, 40:668-670.
27. Stott J.L., Osburn B.I., Barber T.L. The current status of research on an experimental inactivated bluetongue virus vaccine. Proc. Annu. Meet. U S Anim. Health Assoc. 1979, 55-62.
28. Takamatsu H., Burroughs J.N., Wade-Evans A.M., Mertens P.P. Identification of a bluetongue virus serotype 1-specific ovine helper T-cell determinant in outer capsid protein VP2. Virology 1990, 177:396-400.
29. Takamatsu H., Jeggo M.H. Cultivation of bluetongue virus-specific ovine T cells and their cross-reactivity with different serotype viruses. Immunology 1989, 66:258-263.
30. Thiry E., Saegerman C., Guyot H., Kirten P., Losson B., Rollin F., Bodmer M., Czaplicki G., Toussaint J.F., De Clercq K., Dochy J.M., Dufey J., Gilleman J.L., Messeman K. Bluetongue in northern Europe. Vet. Rec. 2006, 159:327.
31. Toussaint J.F., Sailleau C., Breard E., Zientara S., De Clercq K. Bluetongue virus detection by two real-time RT-qPCRs targeting two different genomic segments. J. Virol. Methods 2007, 140:115-123.
32. Umeshappa C.S., Singh K.P., Pandey A.B., Singh R.P., Nanjundappa R.H. Cell-mediated immune response and cross-protective efficacy of binary ethylenimine-inactivated bluetongue virus serotype-1 vaccine in sheep. Vaccine 2010, 28:2522-2531.
33. Wäckerlin R., Eschbaumer M., König P., Hoffmann B., Beer M. Evaluation of humoral response and protective efficacy of three inactivated vaccines against bluetongue virus serotype 8 one year after vaccination of sheep and cattle. Vaccine 2010, 28:4348-4355.
34. Wattegedera S., Sills K., Howard C., Hope J., McInnes C., Entrican G. Variability in cytokine production and cell proliferation by mitogen-activated ovine peripheral blood mononuclear cells: modulation by interleukin IL-10 and IL-12. Vet. Immunol. Immunopathol. 2004, 102:67-76.
35. Worwa G., Scherrer N., Thür B. Serum neutralization test for the detection of antibodies against BTV-8. In: 27. Fachtagung des Arbeitskreises für Veterinärmedizinische Infektionsdiagnostik (AVID) der Deutschen Veterinärmedizinischen Gesellschaft (DVG) mit dem Themenschwerpunkt Virologie. Kloster Banz 2008, p75.
36. Zientara S., MacLachlan N.J., Calistri P., Sánchez-Vizcaíno J.-M., Savini G. Bluetongue vaccination in Europe. Expert Rev. Vaccines 2010, 9:989-991.